Navigation Links
Combo of Tests Might Spot Ovarian Cancer Early
Date:3/10/2009

Preliminary findings offer hope against a silent killer,,

TUESDAY, March 10 (HealthDay News) -- Used together, a blood test and an ultrasound scan may be effective in detecting ovarian cancer in its early and more curable stages, British researchers report.

The two-step detection method could become a new standard in the fight against this deadly and hard to spot malignancy, experts say.

"It appears to be an approach that may be workable," said Robert Smith, director of cancer screening at the American Cancer Society.

The report was published in the March 10 online edition of The Lancet Oncology.

Experts note that, when found early, ovarian cancer is 90 percent curable. But early detection is often impossible, because the disease causes few or no symptoms as it begins. For that reason, 70 percent of cases of ovarian cancer are diagnosed when the cancer has already reached an advanced stage.

In these later stages, the survival rate drops to only 20 percent to 30 percent. For that reason, scientists and doctors have long sought an effective early screening test.

The new study was led by Dr. Usha Menon, head of the Gynaecological Cancer Research Unit at University College London. The team randomly assigned almost 203,000 postmenopausal women to either no ovarian cancer screening or to screening with transvaginal ultrasound plus a blood test that finds a marker for ovarian cancer, called CA125. A third group was screened using transvaginal ultrasound alone.

Between 2001 and 2005, the researchers uncovered 87 ovarian cancers. The specificity of the tests was best in the combined screening group. In that cohort, fewer retests were needed and almost ninefold fewer surgeries were required, the researchers noted.

The team found that screening was able to identify most women with cervical cancer. The combination of the blood test and ultrasound found 90 percent of the cancers, while ultrasound alone found 75 percent of the cancers.

Almost 50 percent of all the cancers found were in an early stage (stage I or II), the researchers noted. And 48 percent of the more invasive ovarian cancers detected were designated as being stage I tumors. Usually, only 28 percent of ovarian cancers are identified in this early stage, the researchers pointed out.

To see whether these screening strategies have an impact on mortality, the women will continue to be screened through 2012 and followed until the end of 2014, the researchers said.

Menon stressed that it's too early to make firm recommendations based on these early findings.

"Preliminary results are encouraging," she said. "Both types of screening can be used on a large scale, and both successfully pick up ovarian cancers. But for a final answer as to whether ovarian cancer screening will save lives, we need to wait till 2015, when the trial will be finished."

For his part, the ACS' Smith said that experts have learned to be cautious when it comes to advocating a particular screening method for ovarian cancer.

"What we have is a long line of disappointing findings using either CA125 alone or ultrasound alone," he explained. But he added that, "in combination, the performance appears to be much better."

Although some women are getting these tests in the United States, women should not be asking to get these tests based on this preliminary data, Smith said. "Right now, the only group of women that is recommended to undergo any testing for ovarian cancer are women who are at very high risk due to family history," he said.

"This screening trial is both a test of whether we can actually deliver these tests and whether we have shown better survival. But more importantly, have we shown that there is a lower rate of ovarian cancer deaths?" Smith said.

More information

For more about ovarian cancer, visit the American Cancer Society.



SOURCES: Usha Menon, M.D., head, Gynaecological Cancer Research Unit, University College London, U.K.; Robert Smith, Ph.D., director, cancer screening, American Cancer Society, Atlanta; March 10, 2009, The Lancet Oncology, online


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Radiation and drug combo helps boost efficacy of lung cancer treatment
2. Aerobic, Weight Training Combo Best Against Diabetes
3. New antibiotic drug combo to speed up treatment of tuberculosis
4. Drug Combo Helps Fight Marfan Syndrome
5. Drug Combo Blocks Pain Without Impairing Movement
6. Two-Drug Combo Fights Brain Tumors
7. CPR, Defibrillator Combo Boosts Cardiac Incident Survival
8. Drug Combo Boosts Multiple Myeloma Survival
9. Drug Combos Effective Against Rheumatoid Arthritis
10. Combo PET/CT Scan Helps Spot Breast Cancers Spread
11. Drug Combo With Antibiotic May Slow MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Combo of Tests Might Spot Ovarian Cancer Early
(Date:1/23/2017)... ... , ... Old School Labs™, makers of the wildly popular all-natural sports supplements ... to its growing team of brand ambassadors. The Olympia top finisher and former Big ... a year was able to turn professional, participating in the 2013 NPC USA Championships ...
(Date:1/23/2017)... ... 23, 2017 , ... “The Inn at the Mill”: a story of love and redemption, ... to become happy and content. , “The Inn at the Mill” is the creation ... Germany and Vermont and is now living in Berks County on Crow Hill. ...
(Date:1/23/2017)... ... ... “Life Under Blankets”: an entrancing story about one woman's travels through ... the creation of published author, Kimberly Mitchell, who earned her bachelor’s degree in English ... pursue a master’s degree in education in the field of curriculum and instruction. Kimberly’s ...
(Date:1/22/2017)... ... 2017 , ... Phytocéane invites clients to take an exotic journey deep into ... ZANZIBAR MILKY CREAM. Inspired by the beauty of Zanzibar, a Tanzanian archipelago off the ... vegetal coral to create this gentle, velvety body cream to envelop the skin in ...
(Date:1/22/2017)... ... ... Medical lab testing through hospitals and other traditional methods can ... take days to arrive to the end customer, having to travel through medical records ... tests, bypassing the cost and delay of traditional means. Now all employees of the ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... Research and Markets has announced the ... Type of Test (Tumor, Clinical Chemistry, Microbiology, Esoteric), By Type ... (Tuberculosis, Influenza, Cancer, HIV/AIDS etc.), Forecast to 2022" report ... ... market segments, especially clinical lab testing, which has evolved as ...
(Date:1/21/2017)... , Jan. 20, 2017 ARMO BioSciences, Inc., ... data on the Company,s lead investigational immuno-oncology drug AM0010 ... by the American Society of Clinical Oncology (ASCO), taking ... CA. "AM0010 induces the ... + T cells in the blood and tumors ...
(Date:1/21/2017)... NEW YORK , Jan. 20, 2017  Faruqi & ... in KemPharm, Inc. ("KemPharm" or the "Company") (NASDAQ: ... against the Company and certain officers and directors and underwriters ... "IPO") to seek the role of lead plaintiff. ... District Court for Johnson County ...
Breaking Medicine Technology: